kConFab Projects
Project NumberInvestigatorsAffiliationProject TitleStarting DateData Submitted
1/03-98
Completed 		J. Kirk, C. Clarke and J. Leary Westmead Hospital Biological and genetic characteristics of normal breast in carriers Mar 1998 Mote et al., 2004
3/10-06
A. Spurdle, G. Chenevix-Trench and D. Easton Queensland Institute of Medical Research Identification of BRCA1/2 modifier genes Aug 1998 Wang et al., 2001; Spurdle et al., 2005; Couch et al., 2007; Antoniou et al., 2007
4/07-99
Completed 		I. Hickie and G. Chenevix-Trench University of New South Wales Prospective psychoimmunological study of women from high-risk breast cancer families Jul 1999
5/07-04
Completed July 2007 		G. Mann Westmead Institute for Medical Research Mapping and identification of novel breast cancer genes Aug 1999 Smith et al., 2006
6/06-03
Completed 		A. Whittemore Stanford University Modifiers of ovarian cancer risk in BRCA1/2 carriers Jun 1999 Whittemore et al., 2005
7/08-99
Completed 		K. Tucker Prince of Wales Hospital Comparison of BRCA1-associated and sporadic ovarian adenocarcinoma Aug 1999 Aghmesheh et al., 2004; Aghmesheh et al., 2005
9/07-00
Completed 		C. Scott Peter MacCallum Cancer Institute Breast cancer penetrance in carriers of a BRCA1 or BRCA2 mutation enrolled in kConFaB Jul 2000 Scott et al., 2003
10/11-06
G. Chenevix-Trench, A. Spurdle, D. Easton, P. Oefner and G. Mann Queensland Institute of Medical Research Candidate gene analysis to search for BRCAx Sep 2000 Marsh et al., 2001; Chenevix-Trench et al., 2002; Thompson et al., 2005, Jekimovs et al., 2005; Johnatty et al., 2007; Cox et al., 2007; Easton et al., 2007
11/12-00
Completed 		I. Campbell Peter MacCallum Cancer Institute Mutation analysis of EP300 in BRCAx families Dec 2000 Campbell et al., 2004
12/12-00
Completed 		J. Leary Westmead Institute for Medical Research Frequency of large deletions in BRCA1 or BRCA2 Dec 2000 Woodward et al., 2005
13/02-01
Completed 		K. Khanna Queensland Institute of Medical Research Identification of familial cases of breast cancer due to non-functional ATM or CHK2 kinase activity Feb 2001 Jekimovs et al., 2005
14/04-01
Completed 		G. Farshid, M. Cummings, R. Balleine and P. Waring Institute of Medical and Veterinary Science Histology of Familial Breast Cancer Apr 2001 Farshid et al., 2006
15/05-01
Completed 		D. Callen Women's and Children's Hospital Is T13 BRCA3? May 2001
16/08-06
K. Phillips Peter MacCallum Cancer Institute Clinical Outcome Project/ Exploring ovarian surveillance and prophylactic surgery amongst high risk women Jan 2004 Phillips et al., 2005
17/06-01
Completed 		G. Mann and G. Pupo Westmead Institute of Cancer Research Genes that influence susceptibility to both breast cancer and melanoma Jun 2001 Data submitted to kConFab
18/03-07
P. Butow, I.Hickie, C. Tennant, K. Tucker, G. Berry and K. Phillips University of Sydney Psychosocial and psychoimmunological predictors of developing breast cancer in women from high risk families Jun 2001
19/07-07
M. Jenkins, J. Hopper, K. Phillips and C. Scott University of Melbourne Environmental modifiers of breast cancer risk in carriers of a germline mutation in BRCA1 or BRCA2 Aug 2001
20/12-01
Completed 		I. Campbell, G. Lindeman, J. Visvader Peter MacCallum Cancer Institute Identification of BRCAx: analysis of genes interacting with the RING and BRCT domains of BRCA1 Dec 2001
21/10-06
A. Spurdle, M. Brown, G Chenevix-Trench, D Goldgar, S Lakhani, Catherine Clarke, S Grimmond, F Couch. Queensland Institute of Medical Research Functional Evaluation of BRCA1 and BRCA2 unclassified sequence variants and identification of critical pathogenic domains Feb 2003; amendment submitted Feb 2005 Southey et al., 2003Phelan et al., 2005Lovelock et al., 2005Chenevix-Trench et al., 2006
23/07-02
Completed 		A. Whittemore Stanford University Genes for Hereditary Ovarian Cancer – are there others beside BRCA1 and BRCA2? Jul 2002
24/07-02
Completed 		A. Whittemore Stanford University Breast cancer risk modifiers in BRCA carriers Jul 2002
26/03-03
Completed 		J. Kirk Westmead Hospital Pathological features of breast cancer in women with dominant-negative mutations in the ataxia telangiectasia mutated (ATM) gene Mar 2003 Balleine et al., 2006
27/P/12-02
became 32/06-03 		M. Brown UQ Adhesion molecules in BRCA1/2 tumours Dec 2002 Wardrop et al., 2005
28/P/02-03
Completed 		G. Kay QIMR Immunofluorescence studies looking for hallmarks of X inactivation in breast cancer Feb 2003
31/07-06
M. Brown University of Queensland Transcriptional and post-transcriptional regulation of the BRCA1 gene Oct 2003
32/06-03
Completed 		M. Brown University of Queensland BRCA1 regulates epithelial morphogenesis and polarity and disruption of these functions contributes to BRCA1 mediated tumorigenesis Oct 2003
33/06-03
Completed 		R. Anderson Peter MacCallum Cancer Institute Expression and localization of caveolin-1 in hereditary breast cancer Oct 2003 Sent list of UPNs used
34/12-06
I. Campbell, G. Chenevix-Trench, J. Sambrook and P. Waring Peter MacCallum Cancer Institute Genome-wide study of loss of heterozygosity to identify breast cancer predisposition genes Jun 2004
35/03-04
Completed 		E. Lobb WA The experiences, attitudes, knowledge and psychological status of men from high risk breast cancer families Jun 2004
36/05-07
G. Chenevix-Trench, S. Grimmond and S. Lakhani QIMR Molecular Profiling of non-BRCA1/2 familial breast cancer Jun 2004; May 2007
37/03-08
S. Tavtigian IARC Candidate breast cancer susceptibility genes: sequence variant discovery and differential expression analysis March 2008
39/04-07
G. Chenevix-Trench QIMR Is there a CpG island methylator phenotype in families with multiple cases of breast cancer Sep 2004; March 2006
40/07-04
Completed 		D. Bowtell and R. van Laar PMCC Expression analysis in ovarian tumours from BRCA1/2 carriers Sep 2004
41/P/09-04
S. Fox University of Oxford The role of FOXP1 in familial breast cancer Nov 2004
42/P/09-04
S. Fox University of Oxford The role of hypoxia in familial breast cancer Nov 2004
43/P/10-04
Not continued 		N. Subramaniam QIMR Relationship between prognosticators of iron overload and breast cancer Jan 2005
44/P/11-04
Completed 		A. Dobrovic PMCC Methylation of BRCA1 in mutation negative BRCA1-like tumours Feb 2005
45/11-04
Completed 		A. Spurdle QIMR Altered X Inactivation Profiles in Breast and Ovarian Cancer May 2005
46/2-05
Completed 		R. Seitz AGI Comparison of BRCA mutation genotypes to immunohistochemically defined phentypes in breast carcinoma May 2005 Data Submitted Oct
48/05-07
G. Lindeman, J. Visvader and J. Sambrook The Walter and Eliza Hall Institute Breast stem cell markers and tumour stem cells in BRCA1, BRC2 and non-BRCA1/2 women Jun 2007
49/10-05
Due for renewal Oct 2008 		J. Schildkraut, T. Rebbeck Duke University Genetic modifiers of BRCA1/2 (GEMS) Oct 2005
50/11-05
D. Huntsman, J. Hopper, M. Southey BC Cancer Agency E-cadherin (CDH-1) a potential susceptibility gene for familial and early lobular breast cancer Feb 2006
51/11-05
S.J. Dawson, J. Sambrook, Y. Antill, D. Goldgar, J. Hopper Peter MacCallum Cancer Centre Prostate cancer in hereditary breast cancer families Mar 2006
52/02-06
P. Butow, C. Tennant, I. Campbell, D. Duffy, M. Price, B. Meiser University of Sydney Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene Mar 2006
53/P/03-06
Completed 		L. Hutschtscha and R. Reddel Children's Medical Research Institute Proliferation life span of LiF syndrome cells Apr 2006
54/03-06
R. Balleine Westmead Institute Insights into mechanisms of breast cancer pathogenesis from tissue pathology Apr 2006
55/05-06
G. Chenevix-Trench, A. deFazio and D. Gertig QIMR Microarray-targeted candidate gene approach to finding ovarian cancer susceptibility genes. Aug 2006
56/07-06
J. Hopper, G. Mann, M. Jenkins, G. Byrnes, J. Dowty, C. Apicella, R. Milne, G. Dite, K. Byth Wilson, L. Baglietto, G. Severi, R. MacInnis, M. Southey and G. Giles University of Melbourne Penetrance and prevalence of BRCA1 and BRCA2 mutations Sep 2006
58/P/08-06
Completed 		M. Tosi INSERM, France Evaluation of exon 1 and 2 duplications of BRCA2 Sep 2006
59/08-06
S. Lakhani and P. Simpson University of Queensland Lobular carcinomas in familial breast cancer Oct 2006
60-09-06
G. Chenevix-Trench, N. Wayte, D. Duffy, G. Suthers, S. Lakhani and M. Brown QIMR Searching for general cancer susceptibility genes Dec 2006
61/P/10-06
G. Chenevix-Trench QIMR Micro RNA profiles in breast and ovarian tumours from kConFaB Nov 2006
62/10-06
S. Lakhani and P. Simpson University of Queensland Exploring variation in the molecular genetic profiles of breast tumours from multiple-case families harbouring the same mutation. Feb 2007
63/12-06
G. Chenevix-Trench, S. Lakhani and P. Simpson QIMR Gene copy analysis of kConFab tumours. Mar 2007
64/12-06
A. Spurdle, Y. Antill, J. Young, D. Duffy, D. Goldgar, S. Lakhani, G. Mann, C. Stewart, P. Webb QIMR Breast-Endometrial cancer genetic predisposition. Apr 2007
65/P/02-07
Due for renewal May 2008 		C. Clyne Prince Henry's Institute Regulation of aromatase by BRCA1 May 2007
66/02-07
S. Neuhausen University of California, Irvine SNPs in the insulin-like growth factor (IGF) pathway and breast cancer risk. Apr 2007
57/07-06
M. Southey, J. Hopper, G. Mann, V. Hayes, M. Jenkins, G. Dite, G. Byrnes, L. Gurrin, J. Dowty, R. Milne, G. Giles, M. McCredie, D. Goldgar University of Melbourne Candidate genes for early-onset breast cancer Dec 2006
68/05-07
G. Chenevix-Trench, G. Lindeman, J., Visvader, S. Lakhani and I. Campbell QIMR, PMCC, WEHI and University of Queensland The role of GATA3 in familial breast tumours July 2007
67/05-07
M. Southey, J. Hopper, M. Jenkins, G. Byrnes and others University of Melbourne Clarifying the contribution of BRIP1 and PALB2 in breast cancer risk July 2007
69/P/08-07
M. Cossai and S. Lakhani University of Queensland Molecular analysis of low grade, triple negative breast carcinomas Aug 2007
70P/09-07
S. Fox PMCC The role of FOXP3 and lymphoid subsets in familial breast cancer Oct 2007
71/09-07
R. Ward and M. Hitchens St Vincent's Hospital, Sydney The role of germ line epimutations of BRCA1 and BRCA2 in early onset and familial breast cancer. Oct 2007
72/10-07
S. Lakhani, G. Chenevix-Trench, G. Lindeman and J. Visvader University of Queensland Establishment of cancer cell lines and isolation of stem cells from metastases and pleural effusions Feb 2008
73/12-07
F. Couch, A. Antoniou and D. Easton Mayo Clinic A genome wide association study for breast cancer in BRCA1 mutation carriers Feb 2008
74P/12-07
S. Fox, I. Haviv, I. Campbell PMCC MicroRNAs in familial basal-like breast cancer Feb 2008
75/-02-08
Full project 		Kelly Phillips, John Hopper, Roger Milne Peter MacCallum Cancer Centre, The University of Melbourne Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers March 2008
76/04-08
Full project 		Ken Offit Memorial Sloan-Kettering Cancer Centre, New York An international study of BRCA2 penetrance June 2008
78P/04-08
Pilot project 		Jennifer Byrne The Children's Hospital at Westmead, Sydney Quantitative IHC analysis of tumour protein D52 expression in breast tissue from patients at high risk of developing hereditary breast cancer. June 2008
#77/04-08
Full project 		Gillian Mitchell, Georgia Trench, Antonis Antoniou, David Goldgar Peter MacCallum Cancer Centre Characterisation of the kConFab BRCAX cohort for selected breast cancer susceptibility loci and their effe.ct on breast cancer risk in this cohort May 2008



The information provided on the kConFab Home Page is for information only, and is not a substitute for talking to a health professional.